Prospect News: News for NanoViricides, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with N > Issuers starting with N, PP only > All stories on NanoViricides, Inc. > Stories on NanoViricides, Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

NanoViricides, Inc.

7/9/2014	PP	NanoViricides settles $5 million placement of convertible debentures
6/25/2014	PP	NanoViricides amends terms of warrants sold in private placements
1/21/2014	PP	NanoViricides arranges $20 million registered direct offering of units
9/12/2013	PP	NanoViricides seals $10.33 million registered direct offering of units
9/10/2013	PP	NanoViricides plans $9.9 million registered direct offering of units
2/1/2013	PP	NanoViricides arranges $6 million placement of convertible debentures
12/28/2012	PP	NanoViricides plans $2.5 million registered direct sale of preferreds
6/28/2012	PP	NanoViricides negotiates $5 million public offering of 10% preferreds
11/1/2011	PP	NanoViricides negotiates $5 million public offering of 10% preferreds
7/27/2011	PP	NanoViricides wraps $2.5 million of $15 million preferreds offering
4/20/2011	PP	NanoViricides seals another $5 million of $7.5 million preferreds sale
4/19/2011	PP	NanoViricides reports $2.5 million registered offering of preferreds
12/22/2010	PP	NanoViricides wraps $5 million private placement of 10% preferreds
9/21/2010	PP	NanoViricides plans $5 million follow-on offering of 10% preferreds
5/12/2010	PP	New Issue: NanoViricides prices $5 million 10% convertible preferred shares
5/12/2010	PP	Market Commentary: Chesapeake eyes another $600 million; Sequenom plans issue; Mesoblast gets acquisition funding
10/6/2009	PP	New Issue: NanoViricides details $5.1 million private placements of common stock
10/5/2009	PP	NanoViricides takes in $4.3 million through common stock placement
7/10/2009	PP	New Issue: NanoViricides consummates $1.05 million private placement of shares
8/29/2008	PP	New Issue: NanoViricides seals $3.29 million private placement of shares
10/18/2007	PP	New Issue: NanoViricides wraps $1.75 million sale of shares, warrants
7/13/2005	BTPP	NanoViricides prices convertible debenture offering

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.